Tagged with medicine

Europe Christoph Stoller, the recently appointed president of Medicines for Europe, outlines the mission of his presidency, how the association and its members are working to tackle the issue of drug shortages across the continent, and the crucial importance of establishing a high-level dialogue between industry and governments. Adrian van den…

China Li Qing of Illumina China discusses his recent move to the company, the strategic significance of the China market to Illumina global, and the competitive landscape for next generation sequencing (NGS) in China.   2018 was a milestone year for Illumina China because we received NMPA approval of our diagnostic…

Taiwan Mengchu Wu, CEO of Health Genetech, introduces the innovative precision medicine company as it prepares to transition from a research-positioned provider to a healthcare partner. Wu goes on to offer her insights on the key market trends impacting the emerging field of precision medicine and shares her outlook on the…

Taiwan Shing-Mou Lee, founder and president of EMO Biomedicine, the leading CDMO provider of cell-based products in Taiwan, discusses the major regulatory and maturation trends in the region and shares his future strategy for expanding the company’s position in the sector.   One of EMO’s missions is to help the government…

Medicine The WHO has published its most recent edition of the Essential Medicines List in July 2019. On the list are 28 new medicines for adults, making a total of 460 total medicines deemed essential, the highest number ever recorded. Below are the 28 new medicines and a graph of number…

Opinion Brendan Shaw, Principal of Shawview Consulting and Adjunct Senior Lecturer at the University of New South Wales, shares highlights from the 2019 World Health Organization’s List of Essential Medicines.   The most recent edition of the World Health Organization’s Model List of Essential Medicines was released on 9 July and…

Opinion Frost & Sullivan’s Senior Research Analyst, Aarti Chitale looks at the sizeable impact that precision medicine, especially regenerative medicine, is already having on the global therapeutic landscape, and how the Asia-Pacific region is positioning itself at the forefront of this trend.   Providing the right treatment/ right drug at the…

Taiwan Dr Jeffery Tzen, president of the Taiwanese Society of Molecular Medicine and precision medicine key opinion leader, offers insights into Taiwan’s adoption of the emerging field.   In order to succeed in translating precision medicine to clinical practice, quality laboratories under strong regulations must be created   What motivates you…

China Serial entrepreneur and Ronnsi CEO Yiming Yao discusses the inspiration behind the company’s formation, its unique specialization in ovine heparin, and his strategy to take the firm to the next level globally.   Currently, I believe that we might be the only company in the world working in the area…

Taiwan Eric Yang, secretary general of the Taiwan Precision Medical and Molecular Diagnostics Industry Association (PMMD), speaks about the key challenges facing the sector and the top priorities of the organization and its member companies. Yang goes on to share his insights on the opportunities that exist for precision medicine and…

Sweden Amy Van Buskirk, general manager of Roche Sweden, discusses the role Roche plays in the Swedish healthcare system, how Sweden is becoming an innovation leader once more as well as a frontrunner in precision medicine, and explains how Roche wants to build strategic partnerships and form lasting relationships in order…

Janssen In this exclusive and wide-ranging interview, Janssen’s EMEA head Kris Sterkens outlines the company’s strategies in Europe, its increasing embrace of digital solutions, and the shift toward pre-emptive and precision treatments. Sterkens also highlights how Janssen is positioning itself in the emerging markets under his remit and how the ongoing…